| NCT02393001 |
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques |
https://ClinicalTrials.gov/show/NCT02393001 |
Completed |
University of Florida |
2017-09-30 |
| NCT03879395 |
Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study |
https://ClinicalTrials.gov/show/NCT03879395 |
Completed |
Sahlgrenska University Hospital, Sweden |
2018-12-31 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT03326973 |
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors |
https://ClinicalTrials.gov/show/NCT03326973 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT03199846 |
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States |
https://ClinicalTrials.gov/show/NCT03199846 |
Completed |
Bristol-Myers Squibb |
2017-10-30 |
| NCT03197636 |
Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients |
https://ClinicalTrials.gov/show/NCT03197636 |
Enrolling by invitation |
Aarhus University Hospital |
2020-07-01 |
| NCT03165422 |
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan |
https://ClinicalTrials.gov/show/NCT03165422 |
Completed |
Bristol-Myers Squibb |
2018-12-29 |
| NCT03165409 |
Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread |
https://ClinicalTrials.gov/show/NCT03165409 |
Completed |
Bristol-Myers Squibb |
2017-09-30 |
| NCT03155217 |
Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old |
https://ClinicalTrials.gov/show/NCT03155217 |
Completed |
University Hospital, Montpellier |
2018-11-30 |
| NCT03139513 |
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU]) |
https://ClinicalTrials.gov/show/NCT03139513 |
Completed |
Hoffmann-La Roche |
2018-08-22 |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
https://ClinicalTrials.gov/show/NCT03050268 |
Recruiting |
St. Jude Children’s Research Hospital |
2037-03-31 |
| NCT02990611 |
Real-Life Efficacy and Safety of Nivolumab Monotherapy or in Combination With Ipilimumab in Patients With Advanced (Unresectable or Metastatic) Melanoma and in Patients With Adjuvant Nivolumab Therapy |
https://ClinicalTrials.gov/show/NCT02990611 |
Recruiting |
Bristol-Myers Squibb |
2024-08-31 |
| NCT02949154 |
Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients |
https://ClinicalTrials.gov/show/NCT02949154 |
Completed |
University Medical Center Groningen |
2017-04-30 |
| NCT02910557 |
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection |
https://ClinicalTrials.gov/show/NCT02910557 |
Recruiting |
Amgen |
2026-08-28 |
| NCT02909348 |
Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab |
https://ClinicalTrials.gov/show/NCT02909348 |
Completed |
Royal Free Hospital NHS Foundation Trust |
2019-10-31 |
| NCT02907086 |
Circulating Tumor Material in Colorectal Cancer and Melanoma |
https://ClinicalTrials.gov/show/NCT02907086 |
Active, not recruiting |
Abramson Cancer Center of the University of Pennsylvania |
2020-08-31 |
| NCT02884362 |
Prospective Melanoma Database |
https://ClinicalTrials.gov/show/NCT02884362 |
Recruiting |
Institut Claudius Regaud |
2026-01-31 |
| NCT02883933 |
Clinical and Histological Features of Head and Neck Melanoma |
https://ClinicalTrials.gov/show/NCT02883933 |
Completed |
CHU de Reims |
2011-12-31 |
| NCT02854488 |
Yervoy Pregnancy Surveillance Study |
https://ClinicalTrials.gov/show/NCT02854488 |
Recruiting |
Bristol-Myers Squibb |
2024-08-31 |
| NCT02854124 |
Tracing Dissemination of Melanoma Cells in Healthy Tissues |
https://ClinicalTrials.gov/show/NCT02854124 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2023-10-31 |
| NCT02847728 |
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice |
https://ClinicalTrials.gov/show/NCT02847728 |
Recruiting |
Bristol-Myers Squibb |
2024-03-31 |
| NCT02828202 |
Follow-up of a National Cohort of Melanoma Stage IV and Unresectable Stage III Patients |
https://ClinicalTrials.gov/show/NCT02828202 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-03-31 |
| NCT02794636 |
Interferon Toxicities in Melanoma Treatment |
https://ClinicalTrials.gov/show/NCT02794636 |
Completed |
Bristol-Myers Squibb |
2015-11-30 |
| NCT02780089 |
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study |
https://ClinicalTrials.gov/show/NCT02780089 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-07-31 |
| NCT02755233 |
Ipilimumab-induced Lung Toxicity: Observational Study |
https://ClinicalTrials.gov/show/NCT02755233 |
Completed |
University of Zurich |
2015-12-31 |
| NCT02739386 |
Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases |
https://ClinicalTrials.gov/show/NCT02739386 |
Completed |
Bristol-Myers Squibb |
2017-03-30 |
| NCT02724488 |
Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies |
https://ClinicalTrials.gov/show/NCT02724488 |
Active, not recruiting |
University Health Network, Toronto |
2020-12-31 |
| NCT02717364 |
Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT02717364 |
Recruiting |
Bristol-Myers Squibb |
2020-06-24 |
| NCT02673970 |
Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT02673970 |
Recruiting |
Universitair Ziekenhuis Brussel |
2020-09-30 |
| NCT02663232 |
Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT02663232 |
Completed |
Hoffmann-La Roche |
2014-10-31 |
| NCT02668887 |
Employment and Quality of Life in Patients With Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT02668887 |
Completed |
Fachklinik Hornheide an der Universität Münster |
2018-08-31 |
| NCT02600169 |
Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab |
https://ClinicalTrials.gov/show/NCT02600169 |
Completed |
University Medical Center Groningen |
2019-04-30 |
| NCT02600143 |
Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. |
https://ClinicalTrials.gov/show/NCT02600143 |
Completed |
University Medical Center Groningen |
2019-04-30 |
| NCT02791594 |
Imaging FDG Flare in Melanoma |
https://ClinicalTrials.gov/show/NCT02791594 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2020-07-01 |
| NCT00040352 |
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma |
https://ClinicalTrials.gov/show/NCT00040352 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02470273 |
Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID) |
https://ClinicalTrials.gov/show/NCT02470273 |
Active, not recruiting |
Rockefeller University |
2021-07-31 |
| NCT02439411 |
Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain |
https://ClinicalTrials.gov/show/NCT02439411 |
Completed |
Grupo Español Multidisciplinar de Melanoma |
2016-09-30 |
| NCT02425475 |
FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA) |
https://ClinicalTrials.gov/show/NCT02425475 |
Completed |
University Hospital Tuebingen |
2016-07-31 |
| NCT02372708 |
Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy |
https://ClinicalTrials.gov/show/NCT02372708 |
Completed |
Chinese PLA General Hospital |
2012-05-31 |
| NCT02352623 |
Quality of Life and Surgical Late Effects of Melanoma Treatment |
https://ClinicalTrials.gov/show/NCT02352623 |
Completed |
Herlev Hospital |
2016-02-29 |
| NCT02332642 |
Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy |
https://ClinicalTrials.gov/show/NCT02332642 |
Completed |
Universitätsmedizin Mannheim |
2016-12-31 |
| NCT02279004 |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
https://ClinicalTrials.gov/show/NCT02279004 |
Recruiting |
Dana-Farber Cancer Institute |
2021-12-31 |
| NCT02224768 |
YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey |
https://ClinicalTrials.gov/show/NCT02224768 |
Completed |
Bristol-Myers Squibb |
2015-11-30 |
| NCT02213471 |
Patient Preference for Biopsy Notification |
https://ClinicalTrials.gov/show/NCT02213471 |
Completed |
University of California, San Francisco |
2013-07-31 |
| NCT02193581 |
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging |
https://ClinicalTrials.gov/show/NCT02193581 |
Completed |
Orlucent, Inc |
2017-12-01 |
| NCT02196246 |
Moletest Clinical Study in Scotland |
https://ClinicalTrials.gov/show/NCT02196246 |
Completed |
Moletest Scotland Ltd |
2016-10-12 |
| NCT02171286 |
The Oncopanel Pilot (TOP) Study |
https://ClinicalTrials.gov/show/NCT02171286 |
Completed |
British Columbia Cancer Agency |
2017-03-31 |
| NCT02177110 |
A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT02177110 |
Active, not recruiting |
Cancer Trials Ireland |
2020-08-31 |
| NCT02143999 |
An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT02143999 |
Completed |
Hoffmann-La Roche |
2016-12-30 |
| NCT02088762 |
Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm) |
https://ClinicalTrials.gov/show/NCT02088762 |
Completed |
University Hospital Inselspital, Berne |
2012-12-31 |
| NCT02074605 |
Cognitive Effects of Interferon in Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT02074605 |
Completed |
University of Arizona |
2010-05-31 |
| NCT02058953 |
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases |
https://ClinicalTrials.gov/show/NCT02058953 |
Completed |
University of Pittsburgh |
2019-08-19 |
| NCT01288963 |
IL-2 “SELECT” Tissue Collection Protocol in Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT01288963 |
Active, not recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02050594 |
Ipilimumab 12-month Intensive Pharmacovigilance Protocol |
https://ClinicalTrials.gov/show/NCT02050594 |
Completed |
Bristol-Myers Squibb |
2015-02-28 |
| NCT04045691 |
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment |
https://ClinicalTrials.gov/show/NCT04045691 |
Recruiting |
Pierre Fabre Pharma GmbH |
2026-12-31 |
| NCT04217382 |
Pre Transplantation Melanoma |
https://ClinicalTrials.gov/show/NCT04217382 |
Recruiting |
Hospices Civils de Lyon |
2022-02-27 |
| NCT03356470 |
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT03356470 |
Enrolling by invitation |
University of Wisconsin, Madison |
2021-03-31 |
| NCT01773655 |
Clinical and Histopathologic Characteristics of BAP1 Mutations |
https://ClinicalTrials.gov/show/NCT01773655 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-06-30 |
| NCT00339222 |
Family Study of Melanoma in Italy |
https://ClinicalTrials.gov/show/NCT00339222 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-06-30 |
| NCT01986712 |
A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma |
https://ClinicalTrials.gov/show/NCT01986712 |
Active, not recruiting |
St. Luke’s Hospital and Health Network, Pennsylvania |
2021-03-31 |
| NCT01955941 |
Vascular Response to Brachytherapy Using Functional OCT |
https://ClinicalTrials.gov/show/NCT01955941 |
Active, not recruiting |
OHSU Knight Cancer Institute |
2021-12-31 |
| NCT01960634 |
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT01960634 |
Completed |
Grupo Español Multidisciplinar de Melanoma |
2015-05-31 |
| NCT01925599 |
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma |
https://ClinicalTrials.gov/show/NCT01925599 |
Recruiting |
Greater Houston Retina Research |
2022-01-31 |
| NCT01920516 |
Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment |
https://ClinicalTrials.gov/show/NCT01920516 |
Recruiting |
International Group of Endovascular Oncology |
2019-06-30 |
| NCT01924923 |
New Biopsy Technique for Uveal Melanoma |
https://ClinicalTrials.gov/show/NCT01924923 |
Completed |
Greater Houston Retina Research |
2015-03-31 |
| NCT01840527 |
Utility of Novel BRAF Test for Melanoma |
https://ClinicalTrials.gov/show/NCT01840527 |
Active, not recruiting |
Massachusetts General Hospital |
2017-03-29 |
| NCT01777802 |
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy |
https://ClinicalTrials.gov/show/NCT01777802 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT01775514 |
A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics |
https://ClinicalTrials.gov/show/NCT01775514 |
Completed |
Hoffmann-La Roche |
2015-10-31 |
| NCT01776905 |
In Vivo Real-time Detection of Circulating Melanoma Cells |
https://ClinicalTrials.gov/show/NCT01776905 |
Recruiting |
University of Arkansas |
2020-08-31 |
| NCT03535077 |
Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging) |
https://ClinicalTrials.gov/show/NCT03535077 |
Recruiting |
Orlucent, Inc |
2020-05-31 |
| NCT01744860 |
Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples |
https://ClinicalTrials.gov/show/NCT01744860 |
Completed |
Hoffmann-La Roche |
2013-04-30 |
| NCT01703585 |
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples |
https://ClinicalTrials.gov/show/NCT01703585 |
Completed |
University Health Network, Toronto |
2018-05-01 |
| NCT03438279 |
Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy |
https://ClinicalTrials.gov/show/NCT03438279 |
Completed |
Bristol-Myers Squibb |
2017-12-28 |
| NCT01558349 |
Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques |
https://ClinicalTrials.gov/show/NCT01558349 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2017-06-27 |
| NCT01556503 |
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis |
https://ClinicalTrials.gov/show/NCT01556503 |
Completed |
OHSU Knight Cancer Institute |
2013-11-30 |
| NCT01531608 |
Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma |
https://ClinicalTrials.gov/show/NCT01531608 |
Completed |
University of Virginia |
2012-02-29 |
| NCT01528774 |
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers |
https://ClinicalTrials.gov/show/NCT01528774 |
Completed |
Comprehensive Cancer Centers of Nevada |
2016-06-30 |
| NCT01511913 |
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT01511913 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-05-11 |
| NCT01482260 |
Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT01482260 |
Completed |
Ruhr University of Bochum |
2012-01-31 |
| NCT01444560 |
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi |
https://ClinicalTrials.gov/show/NCT01444560 |
Completed |
Ruhr University of Bochum |
2011-09-30 |
| NCT01438658 |
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma |
https://ClinicalTrials.gov/show/NCT01438658 |
Recruiting |
Hadassah Medical Organization |
2040-12-31 |
| NCT01433302 |
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass |
https://ClinicalTrials.gov/show/NCT01433302 |
Completed |
M.D. Anderson Cancer Center |
2014-03-31 |
| NCT01388569 |
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim |
https://ClinicalTrials.gov/show/NCT01388569 |
Completed |
Eastern Cooperative Oncology Group |
2011-09-28 |
| NCT01387581 |
Does the Aid of MelaFind Affect Clinical Management Decisions |
https://ClinicalTrials.gov/show/NCT01387581 |
Completed |
MELA Sciences, Inc. |
2012-03-31 |
| NCT01336270 |
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients |
https://ClinicalTrials.gov/show/NCT01336270 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2013-11-30 |
| NCT04334824 |
Hydrochlorothiazide and Risk of Skin Cancer |
https://ClinicalTrials.gov/show/NCT04334824 |
Active, not recruiting |
Canadian Network for Observational Drug Effect Studies, CNODES |
2021-06-30 |
| NCT04272658 |
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy |
https://ClinicalTrials.gov/show/NCT04272658 |
Recruiting |
University Hospital, Brest |
2023-01-31 |
| NCT04253574 |
Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT04253574 |
Completed |
University of Basel |
2017-09-01 |
| NCT04196452 |
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR) |
https://ClinicalTrials.gov/show/NCT04196452 |
Active, not recruiting |
Bristol-Myers Squibb |
2029-03-31 |
| NCT04193956 |
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors |
https://ClinicalTrials.gov/show/NCT04193956 |
Recruiting |
University Medical Center Groningen |
2023-07-31 |
| NCT04169867 |
Polish Microbiome Map |
https://ClinicalTrials.gov/show/NCT04169867 |
Recruiting |
Ardigen |
2020-07-31 |
| NCT04158544 |
Immune Monitoring in Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT04158544 |
Recruiting |
University of Regensburg |
2020-07-31 |
| NCT04154163 |
Appropriate Dosing to Optimise Personalised Cancer Treatments |
https://ClinicalTrials.gov/show/NCT04154163 |
Recruiting |
University of Dundee |
2020-07-30 |
| NCT04146324 |
An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia |
https://ClinicalTrials.gov/show/NCT04146324 |
Recruiting |
Bristol-Myers Squibb |
2025-07-09 |
| NCT04136470 |
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics |
https://ClinicalTrials.gov/show/NCT04136470 |
Recruiting |
Ardigen |
2020-09-30 |
| NCT04095195 |
Registry of Subjects at Risk of Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT04095195 |
Recruiting |
Associazione Italiana per lo Studio del Pancreas |
2044-08-20 |
| NCT04067960 |
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer |
https://ClinicalTrials.gov/show/NCT04067960 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT04056247 |
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments |
https://ClinicalTrials.gov/show/NCT04056247 |
Recruiting |
OncoHost Ltd. |
2021-10-01 |
| NCT04025424 |
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519) |
https://ClinicalTrials.gov/show/NCT04025424 |
Recruiting |
Russian Academy of Medical Sciences |
2021-06-30 |
| NCT03964298 |
Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma |
https://ClinicalTrials.gov/show/NCT03964298 |
Enrolling by invitation |
Institut Curie |
2019-11-30 |
| NCT03946007 |
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors |
https://ClinicalTrials.gov/show/NCT03946007 |
Recruiting |
University Medical Center Groningen |
2021-06-30 |
| NCT03843593 |
A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery |
https://ClinicalTrials.gov/show/NCT03843593 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT03798977 |
Preclinical Validation of New Anti-melanoma Compounds |
https://ClinicalTrials.gov/show/NCT03798977 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2019-12-31 |
| NCT03771859 |
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed |
https://ClinicalTrials.gov/show/NCT03771859 |
Recruiting |
Bristol-Myers Squibb |
2025-12-07 |
| NCT03740503 |
Genomic Investigation of Unusual Responders |
https://ClinicalTrials.gov/show/NCT03740503 |
Active, not recruiting |
University Health Network, Toronto |
2020-11-30 |
| NCT03741231 |
18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy |
https://ClinicalTrials.gov/show/NCT03741231 |
Completed |
University Hospital, Brest |
2018-06-30 |
| NCT03728842 |
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03728842 |
Recruiting |
Indiana University |
2021-03-01 |
| NCT03732560 |
A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US |
https://ClinicalTrials.gov/show/NCT03732560 |
Active, not recruiting |
Bristol-Myers Squibb |
2019-04-30 |
| NCT03696069 |
A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT03696069 |
Active, not recruiting |
Bristol-Myers Squibb |
2019-02-22 |
| NCT03693378 |
A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups |
https://ClinicalTrials.gov/show/NCT03693378 |
Recruiting |
Immunovia, Inc. |
2020-10-31 |
| NCT03663647 |
Advanced Melanoma in Russian Experience |
https://ClinicalTrials.gov/show/NCT03663647 |
Recruiting |
MelanomaPRO, Russia |
2019-01-31 |
| NCT03553329 |
Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK |
https://ClinicalTrials.gov/show/NCT03553329 |
Completed |
Poitiers University Hospital |
2018-06-02 |
| NCT03518814 |
Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM) |
https://ClinicalTrials.gov/show/NCT03518814 |
Completed |
Lille Catholic University |
2018-06-05 |
| NCT03508297 |
Reflectance Confocal Microscopy to Diagnose MM & LM |
https://ClinicalTrials.gov/show/NCT03508297 |
Recruiting |
Skin Care Network Ltd. |
2019-12-31 |
| NCT03450876 |
Long Term Quality of Life in Melanoma Patients in Netherlands |
https://ClinicalTrials.gov/show/NCT03450876 |
Recruiting |
Bristol-Myers Squibb |
2020-05-29 |
| NCT03448497 |
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom |
https://ClinicalTrials.gov/show/NCT03448497 |
Completed |
Bristol-Myers Squibb |
2018-04-27 |
| NCT01253759 |
Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma |
https://ClinicalTrials.gov/show/NCT01253759 |
Completed |
New England Retina Associates |
2009-01-31 |
| NCT01209299 |
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate |
https://ClinicalTrials.gov/show/NCT01209299 |
Completed |
Eastern Cooperative Oncology Group |
2012-02-19 |
| NCT01205815 |
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment |
https://ClinicalTrials.gov/show/NCT01205815 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2020-12-31 |
| NCT01118832 |
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi |
https://ClinicalTrials.gov/show/NCT01118832 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-06-29 |
| NCT01034696 |
Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting |
https://ClinicalTrials.gov/show/NCT01034696 |
Completed |
Royal Marsden NHS Foundation Trust |
2010-01-31 |
| NCT01011153 |
Survey Study - Sensitivity Comparison Between MelaFind and Physician Group |
https://ClinicalTrials.gov/show/NCT01011153 |
Completed |
MELA Sciences, Inc. |
2010-02-28 |
| NCT01004952 |
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection |
https://ClinicalTrials.gov/show/NCT01004952 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-10-31 |
| NCT00974610 |
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. |
https://ClinicalTrials.gov/show/NCT00974610 |
Completed |
Cancer Trials Ireland |
2015-12-31 |
| NCT00952939 |
Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye |
https://ClinicalTrials.gov/show/NCT00952939 |
Completed |
Case Comprehensive Cancer Center |
2012-09-30 |
| NCT00937781 |
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690 |
https://ClinicalTrials.gov/show/NCT00937781 |
Completed |
Eastern Cooperative Oncology Group |
2011-08-08 |
| NCT00937690 |
Pilot Study of Infrared Imaging of Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT00937690 |
Completed |
University of Virginia |
2009-09-30 |
| NCT00928031 |
Long-term Data Collection for Subjects in MDX-010 Studies |
https://ClinicalTrials.gov/show/NCT00928031 |
Completed |
Bristol-Myers Squibb |
2009-04-30 |
| NCT00923026 |
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies |
https://ClinicalTrials.gov/show/NCT00923026 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00901966 |
Sun Exposure and Melanoma in Agricultural Workers |
https://ClinicalTrials.gov/show/NCT00901966 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00897624 |
Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma |
https://ClinicalTrials.gov/show/NCT00897624 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00898183 |
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00898183 |
Completed |
Southwest Oncology Group |
2006-02-28 |
| NCT00897546 |
Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT00897546 |
Completed |
Eastern Cooperative Oncology Group |
2008-07-01 |
| NCT00897520 |
Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy |
https://ClinicalTrials.gov/show/NCT00897520 |
Completed |
Eastern Cooperative Oncology Group |
2010-01-24 |
| NCT00889980 |
Melanoma Molecular Profiling Analysis |
https://ClinicalTrials.gov/show/NCT00889980 |
Completed |
University of Pittsburgh |
2019-07-22 |
| NCT00862914 |
Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi |
https://ClinicalTrials.gov/show/NCT00862914 |
Completed |
Ruhr University of Bochum |
2009-02-28 |
| NCT00912730 |
A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma |
https://ClinicalTrials.gov/show/NCT00912730 |
Completed |
University of Virginia |
NA |
| NCT00849407 |
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma |
https://ClinicalTrials.gov/show/NCT00849407 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT00839410 |
Multicentric Cohort of Melanoma Patients in Ile de France Area |
https://ClinicalTrials.gov/show/NCT00839410 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2019-10-31 |
| NCT03643289 |
Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics |
https://ClinicalTrials.gov/show/NCT03643289 |
Recruiting |
East and North Hertfordshire NHS Trust |
2023-05-02 |
| NCT00832533 |
The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure |
https://ClinicalTrials.gov/show/NCT00832533 |
Completed |
New Mexico Cancer Care Alliance |
2009-02-28 |
| NCT00828126 |
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00828126 |
Completed |
M.D. Anderson Cancer Center |
2012-03-31 |
| NCT03944356 |
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients |
https://ClinicalTrials.gov/show/NCT03944356 |
Recruiting |
EuMelaReg gGmbH |
2021-06-30 |
| NCT03941379 |
A Registry of Patients With Primary Choroidal Melanoma (CM) or Indeterminate Lesions (ILs) |
https://ClinicalTrials.gov/show/NCT03941379 |
Recruiting |
Aura Biosciences |
2029-12-31 |
| NCT03504696 |
Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT03504696 |
Completed |
Bristol-Myers Squibb |
2018-02-20 |
| NCT03319693 |
Molecular Characterization of Primary Mucosal Melanoma |
https://ClinicalTrials.gov/show/NCT03319693 |
Active, not recruiting |
CHU de Reims |
2019-04-28 |
| NCT01990248 |
An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS) |
https://ClinicalTrials.gov/show/NCT01990248 |
Completed |
Hoffmann-La Roche |
2016-07-26 |
| NCT01505400 |
Integrated Molecular Profiling in Advanced Cancers Trial |
https://ClinicalTrials.gov/show/NCT01505400 |
Active, not recruiting |
University Health Network, Toronto |
2021-01-31 |
| NCT00341991 |
Molecular Epidemiology of Cutaneous Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT00341991 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-09-26 |
| NCT00026754 |
Eligibility Screening and Tissue Procurement for the NIH Intramural Research Program Clinical Protocols |
https://ClinicalTrials.gov/show/NCT00026754 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02784366 |
GI Complications in Cancer Immunotherapy Patients |
https://ClinicalTrials.gov/show/NCT02784366 |
Recruiting |
Massachusetts General Hospital |
2020-03-31 |
| NCT02378337 |
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality |
https://ClinicalTrials.gov/show/NCT02378337 |
Completed |
Hospital Sao Rafael |
2015-08-31 |
| NCT02492815 |
PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma |
https://ClinicalTrials.gov/show/NCT02492815 |
Completed |
Bristol-Myers Squibb |
2016-04-30 |
| NCT01489423 |
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim |
https://ClinicalTrials.gov/show/NCT01489423 |
Completed |
Eastern Cooperative Oncology Group |
2013-05-26 |
| NCT03966456 |
Real World Study of Four PD-1 Agents in China |
https://ClinicalTrials.gov/show/NCT03966456 |
Recruiting |
The Affiliated Hospital of Qingdao University |
2021-06-01 |
| NCT00749684 |
Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083) |
https://ClinicalTrials.gov/show/NCT00749684 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-30 |
| NCT00745862 |
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma |
https://ClinicalTrials.gov/show/NCT00745862 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-07-31 |
| NCT00723710 |
Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600) |
https://ClinicalTrials.gov/show/NCT00723710 |
Completed |
Merck Sharp & Dohme Corp. |
2012-09-30 |
| NCT00617799 |
Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma |
https://ClinicalTrials.gov/show/NCT00617799 |
Completed |
University of Nebraska |
2009-02-18 |
| NCT00615095 |
Differential Risks for Melanoma: p16 and DNA Repair |
https://ClinicalTrials.gov/show/NCT00615095 |
Completed |
Memorial Sloan Kettering Cancer Center |
2011-04-30 |
| NCT00597961 |
Health Communication in Families |
https://ClinicalTrials.gov/show/NCT00597961 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-04-14 |
| NCT00591500 |
A Model for Genetic Susceptibility: Melanoma |
https://ClinicalTrials.gov/show/NCT00591500 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-07-31 |
| NCT00581698 |
Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue |
https://ClinicalTrials.gov/show/NCT00581698 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-09-30 |
| NCT00588198 |
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma |
https://ClinicalTrials.gov/show/NCT00588198 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-09-30 |
| NCT00540566 |
Optical Biopsy of Human Skin in Conjunction With Laser Treatment |
https://ClinicalTrials.gov/show/NCT00540566 |
Completed |
University of California, Irvine |
2008-06-30 |
| NCT00536029 |
MicroRNA Expression and Function in Cutaneous Malignant Melanoma |
https://ClinicalTrials.gov/show/NCT00536029 |
Completed |
Rigshospitalet, Denmark |
NA |
| NCT00526032 |
Melanoma Detection by Oblique-Incidence Optical Spectroscopy |
https://ClinicalTrials.gov/show/NCT00526032 |
Completed |
M.D. Anderson Cancer Center |
2012-01-31 |
| NCT00518050 |
Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns |
https://ClinicalTrials.gov/show/NCT00518050 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-07-31 |
| NCT00510302 |
Melanoma Risk-Reduction Among Patients and Family Members |
https://ClinicalTrials.gov/show/NCT00510302 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT00507325 |
Sample Collection From Melanoma Patients |
https://ClinicalTrials.gov/show/NCT00507325 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT00495950 |
Prospective Measurement of Post-Treatment Lymphedema |
https://ClinicalTrials.gov/show/NCT00495950 |
Completed |
M.D. Anderson Cancer Center |
2016-11-30 |
| NCT00450593 |
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma |
https://ClinicalTrials.gov/show/NCT00450593 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT00445783 |
Study of Families With Melanoma |
https://ClinicalTrials.gov/show/NCT00445783 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT00368615 |
Characterization of the Melanoma-Specific Immune Response |
https://ClinicalTrials.gov/show/NCT00368615 |
Recruiting |
University of California, Davis |
2021-04-30 |
| NCT00351728 |
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone |
https://ClinicalTrials.gov/show/NCT00351728 |
Completed |
Jonsson Comprehensive Cancer Center |
2012-08-31 |
| NCT00348088 |
Melanoma Biomarker Study |
https://ClinicalTrials.gov/show/NCT00348088 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2011-09-30 |
| NCT00346008 |
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members |
https://ClinicalTrials.gov/show/NCT00346008 |
Completed |
National Cancer Institute (NCI) |
2008-12-31 |
| NCT00339404 |
Genetic Analysis of Familial Melanoma |
https://ClinicalTrials.gov/show/NCT00339404 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00344799 |
Cytogenetic Study of Ocular Melanoma |
https://ClinicalTrials.gov/show/NCT00344799 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2020-12-31 |
| NCT00288938 |
Natural History Study of Moles and Suspicious Melanoma |
https://ClinicalTrials.gov/show/NCT00288938 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00203008 |
A Survey Study to See if Patients Diagnosed With Parkinson’s Disease Have Higher Incidence of Melanoma |
https://ClinicalTrials.gov/show/NCT00203008 |
Completed |
Teva Pharmaceutical Industries |
NA |
| NCT00132704 |
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation |
https://ClinicalTrials.gov/show/NCT00132704 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-07-31 |
| NCT00001898 |
Microarray Analysis for Human Genetic Disease |
https://ClinicalTrials.gov/show/NCT00001898 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |